{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T20:36:03Z","timestamp":1793738163190,"version":"4.6.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T00:00:00Z","timestamp":1742342400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T00:00:00Z","timestamp":1742342400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1007\/s10072-025-08110-0","type":"journal-article","created":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T04:43:48Z","timestamp":1742359428000},"page":"3263-3269","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["NfL as a biomarker in ATTRv amyloidosis: potential and limitations"],"prefix":"10.1007","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6017-370X","authenticated-orcid":false,"given":"Massimo","family":"Russo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"De Luca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Gentile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"D\u2019Arma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Pugliese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Macaione","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Polito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Licitri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Cafarchio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. H.","family":"Aguennouz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Rodolico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Mazzeo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,19]]},"reference":[{"issue":"3","key":"8110_CR1","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1111\/joim.13169","volume":"289","author":"E Muchtar","year":"2021","unstructured":"Muchtar E, Dispenzieri A, Magen H, Grogan M, Mauermann M, McPhail ED, Kurtin PJ, Leung N, Buadi FK, Dingli D et al (2021) Systemic amyloidosis from A (AA) to T (ATTR): a review. J Intern Med 289(3):268\u2013292. https:\/\/doi.org\/10.1111\/joim.13169","journal-title":"J Intern Med"},{"issue":"5","key":"8110_CR2","doi-asserted-by":"publisher","first-page":"545","DOI":"10.3390\/brainsci11050545","volume":"11","author":"M Russo","year":"2021","unstructured":"Russo M, Gentile L, Di Stefano V, Di Bella G, Minutoli F, Toscano A, Brighina F, Vita G, Mazzeo A (2021) Use of drugs for ATTRv amyloidosis in the real world: how therapy is changing survival in a non-endemic area. Brain Sci 11(5):545. https:\/\/doi.org\/10.3390\/brainsci11050545","journal-title":"Brain Sci"},{"issue":"4","key":"8110_CR3","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1080\/13506129.2020.1794807","volume":"27","author":"M Russo","year":"2020","unstructured":"Russo M, Obici L, Bartolomei I, Cappelli F, Luigetti M, Fenu S, Cavallaro T, Chiappini MG, Gemelli C, Pradotto LG et al (2020) ATTRv amyloidosis Italian registry: clinical and epidemiological data. Amyloid 27(4):259\u2013265. https:\/\/doi.org\/10.1080\/13506129.2020.1794807","journal-title":"Amyloid"},{"issue":"7","key":"8110_CR4","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1136\/jnnp-2021-327909","volume":"93","author":"A Carroll","year":"2022","unstructured":"Carroll A, Dyck PJ, de Carvalho M, Kennerson M, Reilly MM, Kiernan MC, Vucic S (2022) Novel approaches to diagnosis and management of hereditary transthyretin amyloidosis. J Neurol Neurosurg Psychiatry 93(7):668\u2013678. https:\/\/doi.org\/10.1136\/jnnp-2021-327909","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"6","key":"8110_CR5","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.1007\/s00415-019-09688-0","volume":"268","author":"D Adams","year":"2021","unstructured":"Adams D, Ando Y, Beir\u00e3o JM, Coelho T, Gertz MA, Gillmore JD, Hawkins PN, Lousada I, Suhr OB, Merlini G (2021) Expert consensus recommendations to improve diagnosis of ATTR amyloidosis with polyneuropathy. J Neurol 268(6):2109\u20132122. https:\/\/doi.org\/10.1007\/s00415-019-09688-0","journal-title":"J Neurol"},{"issue":"1","key":"8110_CR6","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1080\/13506129.2018.1556156","volume":"26","author":"I Concei\u00e7\u00e3o","year":"2019","unstructured":"Concei\u00e7\u00e3o I, Damy T, Romero M, Gal\u00e1n L, Attarian S, Luigetti M, Sadeh M, Sarafov S, Tournev I, Ueda M (2019) Early diagnosis of ATTR amyloidosis through targeted follow-up of identified carriers of TTR gene mutations. Amyloid 26(1):3\u20139. https:\/\/doi.org\/10.1080\/13506129.2018.1556156","journal-title":"Amyloid"},{"issue":"2","key":"8110_CR7","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1007\/s10072-020-04889-2","volume":"43","author":"F Manganelli","year":"2022","unstructured":"Manganelli F, Fabrizi GM, Luigetti M, Mandich P, Mazzeo A, Pareyson D (2022) Hereditary transthyretin amyloidosis overview. Neurol Sci 43(2):595\u2013604. https:\/\/doi.org\/10.1007\/s10072-020-04889-2","journal-title":"Neurol Sci"},{"issue":"7","key":"8110_CR8","doi-asserted-by":"publisher","first-page":"3770","DOI":"10.3390\/ijms25073770","volume":"25","author":"M Berends","year":"2024","unstructured":"Berends M, Nienhuis HLA, Adams D, Karam C, Luigetti M, Polydefkis M, Reilly MM, Sekijima Y, Hazenberg BPC (2024) Neurofilament light chains in systemic amyloidosis: a systematic review. Int J Mol Sci 25(7):3770. https:\/\/doi.org\/10.3390\/ijms25073770","journal-title":"Int J Mol Sci"},{"issue":"22","key":"8110_CR9","doi-asserted-by":"publisher","first-page":"2247","DOI":"10.1212\/WNL.0000000000001642","volume":"84","author":"CH Lu","year":"2015","unstructured":"Lu CH, Macdonald-Wallis C, Gray E, Pearce N, Petzold A, Norgren N, Giovannoni G, Fratta P, Sidle K, Fish M et al (2015) Neurofilament light chain. Neurology 84(22):2247\u20132257. https:\/\/doi.org\/10.1212\/WNL.0000000000001642","journal-title":"Neurology"},{"key":"8110_CR10","unstructured":"Frontiers (2024) The evolution of neurofilament light chain in multiple sclerosis. Available online: https:\/\/www.frontiersin.org\/articles\/10.3389\/fnins.2021.642384\/full (accessed on 4 February"},{"issue":"4","key":"8110_CR11","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1007\/s13311-022-01237-4","volume":"19","author":"M Benatar","year":"2022","unstructured":"Benatar M, Wuu J, Andersen PM, Bucelli RC, Andrews JA, Otto M, Farahany NA, Harrington EA, Chen W, Mitchell AA et al (2022) Design of a randomized, placebo-controlled, phase 3 trial of Tofersen initiated in clinically presymptomatic SOD1 variant carriers: the ATLAS study. Neurotherapeutics 19(4):1248\u20131258. https:\/\/doi.org\/10.1007\/s13311-022-01237-4","journal-title":"Neurotherapeutics"},{"issue":"3","key":"8110_CR12","doi-asserted-by":"publisher","first-page":"e16070","DOI":"10.1111\/ene.16070","volume":"31","author":"A Romano","year":"2024","unstructured":"Romano A, Primiano G, Antonini G, Ceccanti M, Fenu S, Forcina F, Gentile L, Inghilleri M, Leonardi L, Manganelli F et al (2024) Serum neurofilament light chain: a promising early diagnostic biomarker for hereditary transthyretin amyloidosis? Eur J Neurol 31(3):e16070. https:\/\/doi.org\/10.1111\/ene.16070","journal-title":"Eur J Neurol"},{"key":"8110_CR13","doi-asserted-by":"publisher","first-page":"338","DOI":"10.3389\/fneur.2019.00338","volume":"10","author":"KN Varhaug","year":"2019","unstructured":"Varhaug KN, Torkildsen \u00d8, Myhr KM, Vedeler CA (2019) Neurofilament light chain as a biomarker in multiple sclerosis. Front Neurol 10:338. https:\/\/doi.org\/10.3389\/fneur.2019.00338","journal-title":"Front Neurol"},{"issue":"11","key":"8110_CR14","doi-asserted-by":"publisher","first-page":"523","DOI":"10.3390\/biomedicines8110523","volume":"8","author":"S Thebault","year":"2020","unstructured":"Thebault S, Booth RA, Freedman MS (2020) Blood neurofilament light chain: the neurologist\u2019s troponin? Biomedicines 8(11):523. https:\/\/doi.org\/10.3390\/biomedicines8110523","journal-title":"Biomedicines"},{"key":"8110_CR15","doi-asserted-by":"publisher","first-page":"3400","DOI":"10.1038\/s41467-021-23620-z","volume":"12","author":"NJ Ashton","year":"2021","unstructured":"Ashton NJ, Janelidze S, Al Khleifat A, Leuzy A, van der Ende EL, Karikari TK, Benedet AL, Pascoal TA, Lle\u00f3 A, Parnetti L et al (2021) A multicentre validation study of the diagnostic value of plasma neurofilament light. Nat Commun 12:3400. https:\/\/doi.org\/10.1038\/s41467-021-23620-z","journal-title":"Nat Commun"},{"issue":"5","key":"8110_CR16","doi-asserted-by":"publisher","first-page":"e412","DOI":"10.1212\/WNL.0000000000011090","volume":"96","author":"S Ticau","year":"2021","unstructured":"Ticau S, Sridharan GV, Tsour S, Cantley WL, Chan A, Gilbert JA, Erbe D, Aldinc E, Reilly MM, Adams D et al (2021) Neurofilament light chain as a biomarker of hereditary transthyretin-mediated amyloidosis. Neurology 96(5):e412\u2013e422. https:\/\/doi.org\/10.1212\/WNL.0000000000011090","journal-title":"Neurology"},{"key":"8110_CR17","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1038\/s41598-023-50212-2","volume":"14","author":"J Gonz\u00e1lez-Moreno","year":"2024","unstructured":"Gonz\u00e1lez-Moreno J, Gragera-Mart\u00ednez \u00c1, Rodr\u00edguez A, Borrachero-Garro C, Garc\u00eda-Garrido S, Barcel\u00f3 C et al (2024) Biomarkers of axonal damage to favor early diagnosis in variant transthyretin amyloidosis (A-ATTRv). Sci Rep 14:581. https:\/\/doi.org\/10.1038\/s41598-023-50212-2","journal-title":"Sci Rep"},{"issue":"1","key":"8110_CR18","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1111\/jns.12524","volume":"28","author":"V Loser","year":"2023","unstructured":"Loser V, Benkert P, Vicino A, Lim Dubois Ferriere P, Kuntzer T, Pasquier J, Maceski A, Kuhle J, Theaudin M (2023) Serum neurofilament light chain as a reliable biomarker of hereditary transthyretin-related amyloidosis\u2014A Swiss reference center experience. J Peripher Nerv Syst 28(1):86\u201397. https:\/\/doi.org\/10.1111\/jns.12524","journal-title":"J Peripher Nerv Syst"},{"issue":"4","key":"8110_CR19","doi-asserted-by":"publisher","first-page":"2845","DOI":"10.1007\/s10072-021-05850-7","volume":"43","author":"M Luigetti","year":"2022","unstructured":"Luigetti M, Di Paolantonio A, Guglielmino V et al (2022) Neurofilament light chain as a disease severity biomarker in ATTRv: data from a single-centre experience. Neurol Sci 43(4):2845\u20132848. https:\/\/doi.org\/10.1007\/s10072-021-05850-7","journal-title":"Neurol Sci"},{"issue":"2","key":"8110_CR20","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1080\/13506129.2024.2313218","volume":"31","author":"AS Carroll","year":"2024","unstructured":"Carroll AS, Razvi Y, O\u2019Donnell L et al (2024) Serum neurofilament light chain in hereditary transthyretin amyloidosis: validation in real-life practice. Amyloid 31(2):95\u2013104. https:\/\/doi.org\/10.1080\/13506129.2024.2313218","journal-title":"Amyloid"},{"issue":"2","key":"8110_CR21","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1007\/s40119-021-00226-6","volume":"10","author":"L Gentile","year":"2021","unstructured":"Gentile L, Tournev I, Amass L, Chapman D, Mazzeo A, Barroso F, van Cleemput J, Schmidt H, Gess B, Garcia Pavia P et al (2021) Phenotypic differences of Glu89Gln genotype in ATTR amyloidosis from endemic loci: update from THAOS. Cardiol Ther 10(2):481\u2013490. https:\/\/doi.org\/10.1007\/s40119-021-00226-6","journal-title":"Cardiol Ther"},{"issue":"10","key":"8110_CR22","doi-asserted-by":"publisher","first-page":"5023","DOI":"10.1007\/s10072-024-07562-0","volume":"45","author":"E Galosi","year":"2024","unstructured":"Galosi E, Costanzo R, Forcina F, Morino S, Antonini G, Salvetti M, Lauletta A, Luigetti M, Romano A, Primiano G, Guglielmino V, Fionda L, Garibaldi M, Esposito N, Falco P, Di Pietro G, Truini A, Leonardi L (2024) Serum neurofilament light chain levels correlate with small fiber related parameters in patients with hereditary transthyretin amyloidosis with polyneuropathy (ATTRv-PN). Neurol Sci 45(10):5023\u20135032. https:\/\/doi.org\/10.1007\/s10072-024-07562-0Epub 2024 May 3. PMID: 38700599; PMCID: PMC11422273","journal-title":"Neurol Sci"},{"issue":"2","key":"8110_CR23","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1007\/s40520-021-02054-z","volume":"34","author":"A Ladang","year":"2022","unstructured":"Ladang A, Kovacs S, Lengel\u00e9 L, Locquet M, Reginster JY, Bruy\u00e8re O, Cavalier E (2022) Neurofilament light chain concentration in an aging population. Aging Clin Exp Res 34(2):331\u2013339. https:\/\/doi.org\/10.1007\/s40520-021-02054-z","journal-title":"Aging Clin Exp Res"},{"key":"8110_CR24","doi-asserted-by":"crossref","unstructured":"Significance of oligomeric (2025) and fibrillar species in amyloidosis: insights into pathophysiology and treatment. Available online: https:\/\/www.mdpi.com\/1420-3049\/26\/16\/5091 (accessed on 16 January","DOI":"10.3390\/molecules26165091"},{"key":"8110_CR25","unstructured":"Diagnostic value of cerebrospinal fluid (2024) neurofilament light protein in neurology: a systematic review and meta-analysis. Available online: https:\/\/jamanetwork.com\/journals\/jamaneurology\/fullarticle\/2735955 (accessed on 4 February"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-025-08110-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10072-025-08110-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-025-08110-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T04:45:50Z","timestamp":1749530750000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10072-025-08110-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,19]]},"references-count":25,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["8110"],"URL":"https:\/\/doi.org\/10.1007\/s10072-025-08110-0","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,19]]},"assertion":[{"value":"24 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in compliance with ethical standards.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The patients enrolled in the study provided informed consent.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors declare no conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}